(212) 624-2060Contact Us Access Your Account >>

A.G.P. Transactions – Bookrunner, Co-Manager and Advisor

Soligenix, Inc.

$9,200,000

Sole Book-Runner
Follow-On Offering

NASDAQ: SNGX

June 2018

iBio, Inc.

$17,350,000

Sole Book-Runner
Follow-On Offering

NASDAQ: IBIO

June 2018

Kindred Biosciences, Inc.

$43,999,991

–
Follow-On Offering

NASDAQ: KIN

June 2018

Aqua Metals, Inc.

$28,743,675

–
Registered Direct Offering

NASDAQ: AQMS

June 2018

Kush Bottles

$36,000,000

Registered Direct Offering
Sole Placement Agent

OTC MKT: KSHB

June 2018

NXT-ID

$16,000,000

Senior Secured Term Loan
Placement Agent

NASDAQ: NXTD

May 2018

Heat Biologics, Inc.

$20,700,000

Follow-On Offering
Sole Book-Runner

NASDAQ: HTBX

May 2018

Cocrystal Pharma, Inc.

$8,427,500

Follow-On Offering
Sole Book-Runner

NASDAQ: COCP

May 2018

Terra Tech Corp.

$40,000,000

Private Placement
Sole Placement Agent

OTC MKT: TRTC

March 2018

Ring Energy, Inc.

$75,040,000

–
Follow-On Offering

NYSE MKT: REI

February 2018

A.G.P. Transactions – Bridge Financings

DPW Holdings, Inc.

Debt Financing

NYSD MKT: DPW

May 2018

xG Technology, Inc

Debt Financing

NASDAQ: XGTI

May 2018

Reshape Lifesciences, Inc.

Equity Financing

NASDAQ: RSLS

April 2018

New Age Beverages Corp.

Equity Financing

NASDAQ: NBEV

April 2018

Recent Capital Markets Transactions by A.G.P. Team

Heron Therapeatics, Inc.

150,000,000

Follow-On Offering

NASDAQ: HRTX

CytRx Corporation, Inc.

86,250,000

Follow-On Offering

NASDAQ: CYTR

Stemline Therapeutics, Inc.

69,000,000

Follow-On Offering

NASDAQ: STML

Inovio Pharmaceuticals, Inc.

63,251,610

Follow-On Offering

NASDAQ: INO

Five Oaks Investment Corp.

60,500,000

Initial Public Offering

NYSE MKT: OAKS

Stemline Therapeutics, Inc.

58,850,000

Follow-On Offering

NASDAQ: STML

OFS Capital Corporation

51,000,000

Follow-On Offering

NASDAQ: OFS

TG Therapeutics, Inc.

50,000,000

Follow-On Offering

NASDAQ: TGTX

Sorrento Therapeutics, Inc.

47,250,168

Follow-On Offering

NASDAQ: SRNE

Cancer Genetics, Inc.

46,013,800

Follow-On Offering

NASDAQ: CGIX

Stemline Therapeutics, Inc.

45,000,000

Follow-On Offering

NASDAQ: STML

Neostem, Inc.

40,250,000

Follow-On Offering

NASDAQ: CLBS

Alcobra Ltd.

37,950,000

Follow-On Offering

NASDAQ: ADHD

NephroGenex, Inc.

37,200,000

Initial Public Offering

NASDAQ: NRX

Sorrento Therapeutics, Inc.

34,600,625

Follow-On and Uplisting

NASDAQ: SRNE

Recro Pharma, Inc

34,500,000

Initial Public Offering

NASDAQ: REPH

Evoke Pharma, Inc.

28,980,000

Initial Public Offering

NASDAQ: EVOK

CytRx Corporation

28,778,750

Follow-On Offering

NASDAQ: CYTR

Sorrento Therapeuties, Inc.

28,769,000

Follow-On Offering

NASDAQ: SRNE

Heat Biologics, Inc.

27,000,000

Initial Public Offering

NASDAQ: HTBX

Advaxis, Inc.

26,450,000

Follow-On and Uplisting

NASDAQ: ADXS

Kindred Biosciences, Inc.

25,875,000

Follow-On Offering

NASDAQ: KIN

CytRx Corporation, Inc.

25,875,000

Follow-On Offering

NASDAQ: CYTR

Alcobra Ltd.

25,000,000

Initial Public Offering

NASDAQ: ADHD

Ceres, Inc.

23,000,000

Initial Public Offering

NASDAQ: CERE

Ritter Pharmaceuticalc, Inc.

23,000,000

Follow-On Offering

NASDAQ: RTTR

Top Ships, Inc.

21,325,050

Follow-On Offering

NASDAQ: TOPS

Professional Diversity Network, Inc.

20,500,000

PIPE

NASDAQ: IPDN

Medical Transcription Billing, Corp.

20,400,000

Initial Public Offering

NASDAQ: MTBC

Jaguar Animal Health, Inc.

20,020,000

Initial Public Offering

NASDAQ: JAGX

Ritter Pharmaceuticals, Inc.

20,000,000

Initial Public Offering

NASDAQ: RTTR

Biocept, Inc.

19,000,000

Initial Public Offering

NASDAQ: BIOC

New Age Beverages Corporation

17,250,000

Follow-On and Uplisting

NASDAQ: NBEV

Cancer Genetics, Inc.

16,050,000

Follow-On Offering

NASDAQ: CGIX

SenesTech, Inc.

15,000,000

Initial Public Offering

15,000,000

Globelmmune, Inc.

15,000,000

Initial Public Offering

NASDAQ: GBIM

Advaxis, Inc.

14,076,000

Follow-On Offering

NASDAQ: ADXS

PlasmaTech Biopharmaceuticals, Inc.

14,000,000

Follow-On Offering and Uplisting

NASDAQ: PTBI

Cellectar Biosciences, Inc.

12,500,000

Follow-On and Uplisting

NASDAQ: CLRB

Aldeyra Therapeuties, Inc.

12,000,000

Initial Public Offering

NASDAQ: ALDX

SMTP, Inc.

11,500,000

Follow-On Offering and Uplisting

NASDAQ: SMTP

Copsync, Inc.

10,600,000

Follow-On and Uplisting

NASDAQ: COYN

Semler Scientific, Inc.

10,010,000

Initial Public Offering

NASDAQ: SMLR

Eyegate Pharmaceuticals, Inc.

10,000,000

Follow-On and Uplisting

NASDAQ: EYEG

Cytosorbents Corporation

10,000,000

Follow-On Offering

NASDAQ: CTSO

BiondVax Pharmaceuticals Ltd.

9,550,000

Initial Public Offering

NASDAQ: BVXV

Micronet Enertec Technologies, Inc.

9,325,000

Follow-On and Uplisting

NASDAQ: MICT

Tonix Pharmaceuticalc

9,200,000

Follow-On Offering

NASDAQ:: TNXP

MYnd Analytics, Inc.

8,793,750

Follow-On and Uplisting

NASDAQ: MYND

Signal Genetics, Inc.

8,500,000

Initial Public Offering

NASDAQ: SGNL

Ocean Power Technologies, Inc.

8,150,000

Follow-On Offering

NASDAQ: OPTT

Boxlight Corp.

7,000,000

Initial Public Offering

NASDAQ: BOXL

Citius Pharmaceuticalc, Inc.

6,800,000

Follow-On and Uplisting

NASDAQ: CTXR

Precipio, Inc.

6,000,000

Follow-On and Uplisting

NASDAQ: PRPO

Eastside Distilling, Inc.

5,400,000

Follow-On and Uplisting

NASDAQ: ESDI

DarioHealth Corporation

4,280,000

Private Placement

NASDAQ: DRIO